Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glutamate receptor ligands.

V Neugebauer1

  • 1Department of Neuroscience and Cell Biology, The University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1069, USA. voneugeb@utmb.edu

Handbook of Experimental Pharmacology
|November 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular signatures of maladaptive plasticity in the amygdala in a rat model of chronic neuropathic pain.

bioRxiv : the preprint server for biology·2026
Same author

Fecal Microbiota Transplantation Modulates Gut Microbiome Composition and Glial Signaling in Brain and Colon of Rats with Neuropathic Pain: Evidence for Microbiota-Gut-Brain Axis.

The Journal of frailty & aging·2024
Same author

Correction to "Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis".

ACS chemical neuroscience·2022
Same author

Metabotropic glutamate receptors: novel targets for pain relief.

Expert review of neurotherapeutics·2009
Same author

The effect of a kainate GluR5 receptor antagonist on responses of spinothalamic tract neurons in a model of peripheral neuropathy in primates.

Pain·2004
Same author

Peripheral metabotropic glutamate receptors: fight the pain where it hurts.

Trends in neurosciences·2001
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Glutamate receptors modulate brain excitability and are key in neuroplasticity and nervous system disorders. Targeting these receptors shows therapeutic potential for pain management.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Glutamate is a primary excitatory neurotransmitter.
  • Glutamate receptors are crucial for neurotransmission and neuronal excitability.
  • Dysregulation of glutamatergic signaling contributes to nervous system disorders and pain.

Purpose of the Study:

  • To review glutamate receptor classification.
  • To examine the role of glutamate receptors in nociceptive processing.
  • To discuss the therapeutic potential of glutamate receptor ligands.

Main Methods:

  • Literature review of glutamate receptor functions.
  • Analysis of preclinical pain models.
  • Examination of clinical studies on glutamate receptor ligands.

Related Experiment Videos

Main Results:

  • Glutamate receptors are diverse and play significant roles in central and peripheral pain pathways.
  • Evidence supports the therapeutic value of targeting specific glutamate receptors for pain relief.

Conclusions:

  • Understanding glutamate receptor subtypes is vital for developing novel pain therapies.
  • Glutamate receptor modulation offers a promising avenue for treating pain-related disorders.